Reata Pharmaceuticals, Inc. Gains 23.78%
Wed, May 19, 2021 at 05:33 PM
Reata Pharmaceuticals, Inc. (RETA:NASDAQ) rocketted at $102.63, a gain of 23.8%. The stock got featured on our News Catalysts scanner on Wed, May 19, 2021 at 01:18 PM in the 'BIOTECH' category. From Tue, May 04, 2021, the stock recorded 40.00% Up Days and 45.45% Green Days
The share price of the company has been moving sideways in recent weeks.
About Reata Pharmaceuticals, Inc. (RETA:NASDAQ)
Reata Pharmaceuticals Inc is a clinical stage biopharmaceutical company engaged in identifying, developing, and commercializing product candidates to address rare and life-threatening diseases by targeting molecular pathways.
Top 10 Gainers:
- MoSys, Inc. (MOSY:NASDAQ), 44.06%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%
- Reata Pharmaceuticals, Inc. (RETA:NASDAQ), 23.78%
- VERA (VERA:NASDAQ), 23.56%
- Advaxis, Inc. (ADXS:NASDAQ), 18.65%
- Acasti Pharma Inc. (ACST:NASDAQ), 18%
- Transcat, Inc. (TRNS:NASDAQ), 17.95%
- Home Federal Bancorp, Inc. of Louisiana (HFBL:NASDAQ), 17.92%
- HyreCar Inc. (HYRE:NASDAQ), 17.61%
- LFMD (LFMD:NASDAQ), 16.59%